N-Acetylcysteine and contrast-induced nephropathy: A meta-analysis of 13 randomized trials

This publication has 24 references indexed in Scilit:

• 2656 Can N-acetylcysteine really prevent contrast-induced nephropathy in patients with chronic renal insufficiency? A randomized study and pooled analysis
  European Heart Journal, 2003
• Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast
  Catheterization and Cardiovascular Interventions, 2003
• A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography
  Kidney International, 2002
• Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathy
  Catheterization and Cardiovascular Interventions, 2002
• The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency
  Journal of the American College of Cardiology, 2000
• Use of dopamine in prevention of contrast induced acute renal failure — A randomised study
  International Journal of Cardiology, 1996
• Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application
  Kidney International, 1994
• Contrast Nephrotoxicity: A Randomized Controlled Trial of a Nonionic and an Ionic Radiographic Contrast Agent
  New England Journal of Medicine, 1989
• Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or Both
  New England Journal of Medicine, 1989
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986